A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time

BMC Biotechnol. 2002 May 2:2:8. doi: 10.1186/1472-6750-2-8.

Abstract

Background: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity.

Results: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10(-6). The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow.

Conclusions: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research.It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adult
  • Blood Coagulation Tests / instrumentation*
  • Female
  • Fibrin / metabolism
  • Humans
  • Hypertriglyceridemia / blood
  • Kinetics
  • Male
  • Middle Aged
  • Serum Globulins / metabolism*

Substances

  • Serum Globulins
  • Fibrin